Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Avacta Group PLC
AVCTCurrent price
54 GBX
+3.98 GBX (+8.00%)
Last closed
50 GBX
Company
www.avacta.com
ISIN
GB00BYYW9G87
Sector
Healthcare
Industry
Biotechnology
Exchange
London Exchange
Capitalization
210 740 694 GBX
Yield for 12 month
-62.50 %
1Y
3Y
5Y
10Y
15Y
AVCT
Avacta Group Plc develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally. The company operates through Diagnostics and Therapeutics segments. It provides its proprietary Affimer and pre|CISION technology platforms, which is used to deliver a portfolio of differentiated th therapeutic and diagnostic products that addresses various markets. The company develops AVA6000, a peptide drug conjugate form of doxorubicin that is in Phase I clinical trial to treat locally advanced or metastatic solid tumour; AVA3996, a tumor-activated proteasome inhibitor based on Velcade; and AVA032, a bispecific molecule which is in pre-clinical trials that regulates the activation and proliferation of immune cells. It develops AVA-028-PD-L1 Affimer/ImmunoCytokines; AVA-021 - PD-L1 Affimer/LAG-3 Affimer; and TMAC platform that utilizes the proprietary pre|CISION substrate to provide for the selective release of a drug moiety by FAPa. The company has a collaboration agreement with LG Chem for developing and commercializing Affimer based therapeutics. Avacta Group Plc was incorporated in 2003 and is based in Wetherby, the United Kingdom. Address: Thorp Arch Estate, Wetherby, United Kingdom, LS23 7FA
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
4 587.82 GBXP/E ratio
–Dividend Yield
–Current Year
+2 325 306 178 GBX
Last Year
+965 551 690 GBX
Current Quarter
+1 126 393 659 GBX
Last Quarter
+1 136 096 176 GBX
Current Year
+757 497 457 GBX
Last Year
+423 210 342 GBX
Current Quarter
+305 379 578 GBX
Last Quarter
+449 717 252 GBX
Key Figures AVCT
1 year
3 years
5 years
10 years
EBITDA
-28 524 473 GBX
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-21.8 %
PEG Ratio
–
Return On Equity TTM
-73.02 %
Wall Street Target Price
4 587.82 GBX
Revenue TTM
22 624 898 GBX
Book Value
0.14 GBX
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-5.3 %
Dividend Yield
–
Gross Profit TTM
6 194 615 GBX
Earnings per share
-0.09 GBX
Diluted Eps TTM
-0.09 GBX
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-114.45 %
Dividend Analytics AVCT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AVCT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:100
Payout Ratio
–
Last Split Date
26.01.2016
Dividend Date
–
Stock Valuation AVCT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
8.6189
Price Sales TTM
9.3985
Enterprise Value EBITDA
-12.0368
Price Book MRQ
4.2617
Financials AVCT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AVCT
For 52 weeks
39.51 GBX
152.04 GBX
50 Day MA
63.44 GBX
Shares Short Prior Month
–
200 Day MA
62.46 GBX
Short Ratio
–
Shares Short
–
Short Percent
78 %
BeatStart